“CLINICAL OBSERVATION OF THE USE OF ORAL VINORELBINE IN THE TREATMENT OF DISSEMINATED ESTROGEN-RECEPTORPOSITIVE, HER2-NEGATIVE BREAST CANCER”. World Bulletin of Social Sciences 7 (February 10, 2022): 1–4. Accessed March 31, 2026. https://scholarexpress.net/index.php/wbss/article/view/514.